These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4941049)

  • 1. Accelerated rejection of allogeneic skin grafts in the mouse after injections of histocompatibility antigens solubilized by Triton, butanol, and papain.
    Harris TN; Harris S; Ogburn CA; Bocchieri MH; Farber MB
    Transplantation; 1971 Dec; 12(6):459-63. PubMed ID: 4941049
    [No Abstract]   [Full Text] [Related]  

  • 2. Solubilization of H-2 histocompatibility antigens of the mouse by Triton X-100 and butanol.
    Harris TN; Harris S; Ogburn CA
    Transplantation; 1971 Dec; 12(6):448-58. PubMed ID: 5120095
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenic properties of papain-solubilized alloantigen.
    Graff RJ; Nathenson SG
    Transplant Proc; 1971 Mar; 3(1):249-52. PubMed ID: 4106320
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged skin allograft survival in mice pretreated with soluble transplantation antigens.
    Rosenberg EB; Mann DL; Hill JJ; Fahey JL
    Transplantation; 1971 Nov; 12(5):402-5. PubMed ID: 4948693
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation of dialyzable histocompatibility antigen from BALB-c mice (cell-membrane fragments-proteolytic digestion-detergent solubilization).
    Kerman RH; Harris TN; Harris S
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):223-7. PubMed ID: 4500549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active enhancement of rat renal allografts with papain-released specific antigens.
    von Haefen U; Wren SF; Shaipanich T; Martins AC; Busch GJ; Wilson RE
    Transplantation; 1973 Oct; 16(4):295-303. PubMed ID: 4126788
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of the immunogenic and serological activity of soluble H-2 transplantation antigens in the mouse.
    Strober S; Appella E; Law LW
    Transplant Proc; 1971 Mar; 3(1):246-8. PubMed ID: 4106319
    [No Abstract]   [Full Text] [Related]  

  • 8. Conditioning of allogeneic mice with crude and purified H-2 extracts, alone and combined with cyclophosphamide, for skin graft prolongation.
    Halle-Pannenko O; Martyré MC; Jolles P
    Transplant Proc; 1971 Mar; 3(1):257-9. PubMed ID: 4937892
    [No Abstract]   [Full Text] [Related]  

  • 9. Identical physicochemical properties of three soluble HL-A substances from human liver or spleen.
    Molea G; Sanderson AR
    Transplant Proc; 1971 Mar; 3(1):237-9. PubMed ID: 4106316
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on transplantation immunity. 1. The nature of the response to allogeneic 51 Cr-labeled lymphoid cells and its relationship to homograft immunity.
    Bainbridge DR; Gowland G
    Cell Immunol; 1971 Apr; 2(2):115-27. PubMed ID: 4940997
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological and immunogenic activity of soluble mouse transplantation antigens controlled by the H-2 locus.
    Strober S; Appella E; Law LW
    Proc Natl Acad Sci U S A; 1970 Oct; 67(2):765-72. PubMed ID: 5289019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological enhancement of skin grafts in the mouse.
    Jeekel JJ; McKenzie IF; Winn HJ
    J Immunol; 1972 Apr; 108(4):1017-24. PubMed ID: 4112414
    [No Abstract]   [Full Text] [Related]  

  • 13. Soluble transplantation antigens. Further studies of their tolerogenic properties.
    Law LW; Appella E; Strober S; Wright PW; Fischetti T
    Transplantation; 1974 Dec; 18(6):487-95. PubMed ID: 4612886
    [No Abstract]   [Full Text] [Related]  

  • 14. Skin grafts and allogeneic tumor growth in mice.
    Colmerauer ME; Rumi L; Saal F; Pasqualini CD
    Medicina (B Aires); 1974; 34(5):471-5. PubMed ID: 4612291
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive effects of bacterial asparaginase on antibody formation and allograft immunity.
    Friedman H; Chakrabarty AK
    Immunology; 1971 Dec; 21(6):989-1001. PubMed ID: 4943151
    [No Abstract]   [Full Text] [Related]  

  • 16. Acceleration of graft rejection by pretreatment of the graft donor with recipient cells (donor sensitization).
    Harris NS; Van Alten PJ
    Cell Immunol; 1974 Mar; 11(1-3):342-53. PubMed ID: 4616764
    [No Abstract]   [Full Text] [Related]  

  • 17. Connection between the anti-organ and anti-nuclear titres of antilymphocyte sera and their inhibitory effect on skin graft rejection in mice.
    Fekete B; Petrányi G; Szegedi G; Szabó G
    Haematologia (Budap); 1971; 5(4):419-23. PubMed ID: 4948255
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific unresponsiveness to skin allografts in mice. I. Properties of tissue extracts and their synergistic effect with antilymphocytic serum.
    Brent L; Hansen JA; Kilshaw PJ; Thomas AV
    Transplantation; 1973 Jan; 15(1):160-71. PubMed ID: 4575919
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of immunological tolerance to soluble histocompatibility-2 antigens of mice.
    Law LW; Appella E; Strober S; Wright PW; Fischetti T
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1858-62. PubMed ID: 4114856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.